Academic literature on the topic 'Screening immunoassay'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Screening immunoassay.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Screening immunoassay"

1

Armbruster, D. A., R. H. Schwarzhoff, E. C. Hubster, and M. K. Liserio. "Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening." Clinical Chemistry 39, no. 10 (1993): 2137–46. http://dx.doi.org/10.1093/clinchem/39.10.2137.

Full text
Abstract:
Abstract The newest formulation of the Syva EMIT assay for drugs of abuse, EMIT II, and a new immunoassay, OnLine (Roche), utilizing the kinetic interaction of microparticles in solution (KIMS) methodology, RIA tests, and TDx fluorescence polarization immunoassay (FPIA) procedures were compared for marijuana, cocaine, opiates, and barbiturates. Both EMIT II and OnLine immunoassays were performed with a Hitachi 717 analyzer. Calibration curves, the degree of separation between negative and cutoff calibrators, precision, likelihood of carryover from positive to negative samples, and overall ease and speed of analysis were evaluated. RIA and OnLine detected 99% of gas chromatography/mass spectrometry (GC/MS)-confirmed marijuana samples; TDx, 95%; and EMIT II, 88%. All four immunoassays detected approximately 99% of confirmed cocaine-positive urines. RIA, OnLine, and TDx all detected 100% of opiate-confirmed samples; EMIT II, 97%. Barbiturate assays exhibited the greatest disparity, with OnLine and TDx detecting 100% of confirmed positives; EMIT II, 88%; and RIA, 78%. For a variety of reasons, we prefer the fully automated EMIT II and OnLine assays for high-volume urine testing, in comparison with our laboratory's semiautomated RIA tests and the limited-throughput TDx system. The four immunoassays investigated delivered comparable performance in terms of detection rates for GC/MS-confirmed positives for some drugs but not for others.
APA, Harvard, Vancouver, ISO, and other styles
2

Armbruster, D. A., E. C. Hubster, M. S. Kaufman, and M. K. Ramon. "Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening." Clinical Chemistry 41, no. 1 (1995): 92–98. http://dx.doi.org/10.1093/clinchem/41.1.92.

Full text
Abstract:
Abstract Large numbers of specimens (5000-18,000) were screened for amphetamines, barbiturates, cocaine, marijuana, opiates, and phencyclidine by RIA (Roche), Emit II (Syva), and a new immunoassay, CEDIA (cloned enzyme donor immunoassay, Microgenics). All immunoassays performed equivalently for cocaine, opiates, and phencyclidine. All immunoassays detected the same amphetamine/methamphetamine-positive specimens, but all also detected numerous specimens containing cross-reacting sympathomimetic amines. CEDIA detected 100%, Emit II 93%, and RIA 82% of the barbiturate-positive specimens. Emit II and CEDIA detected 86-88% of the specimens found by RIA to be marijuana positive. A subset of specimens was additionally screened by OnLine (Roche) and TDx (Abbott) for amphetamines, cocaine, and marijuana. OnLine and TDx also detected all of the amphetamine-positive specimens and numerous specimens containing cross-reacting sympathomimetic amines. All immunoassays performed equivalently for cocaine, and the four nonisotopic tests detected 86-89% of the marijuana positives found by RIA. Interfering sympathomimetic amine drug compounds can be eliminated by using an oxidizing agent, thus decreasing the number of unconfirmable amphetamine presumptive positives. The CEDIAs for all of the major drugs of abuse are reliable and effective for large-volume urine screening programs.
APA, Harvard, Vancouver, ISO, and other styles
3

Ehm, M., and A. Kappel. "Immunoassays for diagnosis of coagulation disorders." Hämostaseologie 30, no. 04 (2010): 194–201. http://dx.doi.org/10.1055/s-0037-1619055.

Full text
Abstract:
SummaryImmunoassays play a pivotal role in the clinical laboratory. In the coagulation section of the laboratory, they are used as an aid for diagnosis of deep vein thrombosis or pulmonary embolism, thrombophilia screening, or detection of coagulation factor deficiencies, respectively. Enzyme-linked immunosorbent assay (ELISA) and latex agglutination immunoassay technologies are currently most widely used, while Luminescent Oxygen Channeling Immuno - assay (LOCI®) and other chemiluminescencebased immunoassays are emerging technologies for the coagulation laboratory. However, not all immunoassay technologies employed are compatible with the workflow requirements of the coagulation laboratory, and, not all technologies are suitable for detection or quantification of every marker.This review focuses on technical and performance aspects of those immunoassay technologies that are most widely used in the coagulation laboratory, and provides a description of markers that are typically tested by immunoassays.
APA, Harvard, Vancouver, ISO, and other styles
4

Lukefahr, Ashley, and Barun De. "Laboratory Diagnosis of HIV in the Outpatient Setting: One Hospital’s Perspective." American Journal of Clinical Pathology 152, Supplement_1 (2019): S20—S21. http://dx.doi.org/10.1093/ajcp/aqz112.040.

Full text
Abstract:
Abstract Traditional methods for the diagnosis of human immunodeficiency virus types 1 and 2 (HIV-1, HIV-2) involve initial screening by an immunoassay followed by a specific method Western blot. However, Western blot is not sensitive compared to third-generation immunoassay, which detects both IgG and IgM antibodies against viral envelope proteins causing false-positive results. In addition, neither initial screening nor confirmatory Western blot is capable of detecting acute infection earlier in the disease process, when the virus is more adaptable and highly infectious. To detect both acute and established infection, Abbott Architect platform introduced a new fourth-generation antigen/antibody initial screening assay in 2013. Also, to reduce false-negative results from Western blot, an alternate method Bio-Rad multisport immunoassay was recommended by the Centers for Disease Control and Prevention (CDC) that has higher sensitivity and can differentiate HIV-1 and HIV-2 infections. In 2014, the CDC released updated recommendations for the laboratory diagnosis of HIV. The CDC diagnostic algorithm recommends an initial combination immunoassay that detects HIV-1 and HIV-2 antibodies, followed by supplemental testing with an immunoassay that differentiates HIV-1 and HIV-2 antibodies. Specimens reactive on the initial antigen/antibody immunoassay but nonreactive or indeterminate on the differentiation immunoassay should be followed by nucleic acid testing (NAT) for resolution of this discrepancy. The objective of our study was to review the effect of this updated testing algorithm on HIV testing results in the outpatient setting at Banner University Medical Center–Tucson in Tucson, Arizona. Our study utilized laboratory information system queries to retroactively review all outpatient HIV laboratory testing results obtained from 2013 to 2017. A total of 17,397 HIV-1/2 antigen/antibody immunoassays were performed during this time period. Of the initial antigen/antibody immunoassays, 1.1% were reactive (n = 183). Of these reactive tests, 85% were collected from individuals with established HIV infections (n = 155). HIV-1/HIV-2 antibody differentiation assays were performed on 175 patients, with 86% reactive (n = 150), 2.3% indeterminate (n = 4), and 12% nonreactive (n = 21). Acute HIV-1 infections (antigen/antibody immunoassay reactive, antibody differentiation immunoassay nonreactive or indeterminate, and NAT positive) accounted for 2.7% of patients with reactive initial antigen/antibody immunoassays and 0.03% of all patients screened for HIV infection with the initial antigen/antibody immunoassay (n = 5). Viral loads in the patients with acute HIV-1 infection ranged from 173,000 to >10,000,000 copies/mL. No HIV-2 infections were identified in our patient population. Given that the previous CDC testing algorithm for HIV-1 failed to identify acute HIV-1 infections, our data, which confirm the ability of the current CDC algorithm to detect HIV-1 infections, represent important information for infectious disease practitioners, public health officials, and laboratory directors.
APA, Harvard, Vancouver, ISO, and other styles
5

Kaufman, Bennett M., and Marion Clower. "Immunoassay of Pesticides: An Update." Journal of AOAC INTERNATIONAL 78, no. 4 (1995): 1079–90. http://dx.doi.org/10.1093/jaoac/78.4.1079.

Full text
Abstract:
Abstract Measurement of levels of pesticide residues in foods and crops most often requires extensive cleanup and instrumental techniques such as gas chromatography. Immunoassay measurement techniques, on the other hand, may be used directly on the test portion or require only minimal cleanup. Further refinements of the common antibody–enzyme-based solid-phase assays, such as use of coated magnetic particles, antibody-coated crystals, and continuous-flow devices, have extended the measurement range and applicability of these assays. Likewise, new immunoassays for pesticides have been developed, and existing assays have been refined, optimized, and more completely characterized and validated. In addition to their ability to accurately and reliably measure amounts of residues present in food and crops, immunoassays can be readily used as rapid screening methods for contaminants in field samples. We have previously reviewed much of the work in the area of pesticide immunoassay; this report updates previous information and discusses some new immunoassay techniques.
APA, Harvard, Vancouver, ISO, and other styles
6

Dawood, Sadia, Ayesha Hafeez, Aamir Ijaz, Summera Moeen, Asif Ali Memon, and Sumaira Mubarik. "DIAGNOSTIC ACCURACY OF DRUG SCREENING IMMUNOASSAYS IN DRUG FACILITATED CRIMES." PAFMJ 71, no. 1 (2021): 101–06. http://dx.doi.org/10.51253/pafmj.v71i1.3167.

Full text
Abstract:
Objective: To determine the diagnostic accuracy of immunoassays in drug screening as required in emergency for the rapid diagnosis of drug intoxication in travel related crimes.
 Study Design: Diagnostic accuracy study.
 Place and Duration of Study: department of Chemical Pathology and Endocrinology, Armed Forces Institute ofPathology, Rawalpindi Pakistan, from Jul 2017 to Jun 2018.
 Methodology: Sealed urine specimens of 77 patients with history of suspected intoxication in drugs facilitatedstreet crimes, received for toxicology screening were included in the study. All the specimens were analysed,initially on immunoassay (index test) and then on Triple Quadrupole Liquid chromatography–Mass spectrometry (reference standard). Benzodiazepine being the main class of drugs involved in travel related crimes, diagnostic accuracy of immunoassay technique was assessed for these by calculating its sensitivity, specificity, positive predictive value and negative predictive value.
 Results: Victims were predominantly males and public transportation was the most common mode of transport. The most commonly used drug was Lorazepam. Immunoassay failed to detect few cases who were shown to be intoxicated with benzodiazepines by liquid-chromatography tandem mass spectrometry. The false negative rate was 4.9%. Only one false positive case was observed. The accuracy was calculated to be 94.8% with sensitivity of 95.08% and specificity of 93.7%.
 Conclusion: Immunoassay was found reliable for rapid testing in drug facilitated intoxication cases. Howevercritical decision making should be done cautiously keeping in mind the limitations associated with thesescreening procedures.
APA, Harvard, Vancouver, ISO, and other styles
7

Lin, Yen-Heng, Chih-Ching Wu, Wan-Ling Chen, and Kai-Ping Chang. "Anti-p53 Autoantibody Detection in Automatic Glass Capillary Immunoassay Platform for Screening of Oral Cavity Squamous Cell Carcinoma." Sensors 20, no. 4 (2020): 971. http://dx.doi.org/10.3390/s20040971.

Full text
Abstract:
The incidence of oral squamous cell carcinoma (OSCC), which is one of the most common cancers worldwide, has been increasing. Serum anti-p53 autoantibody is one of the most sensitive biomarkers for OSCC. Currently, the most commonly used method on clinical screening platforms is the enzyme-linked immunosorbent assay, owing to its high specificity and repeatability. However, conducting immunoassays on 96-well plates is typically time consuming, thereby limiting its clinical applications for fast diagnosis and immediate prognosis of rapidly progressive diseases. The present study performed immunoassays in glass capillaries of 1-mm internal diameter, which increases the surface to volume ratio of the reaction, to shorten the time needed for immunoassay. The immunoassay was automated while using linear motorized stages and a syringe pump. The results indicated that, when compared with the 96-well plate immunoassay, the glass capillary immunoassay decreased the reaction time from typical 120 min to 45 min, reduced the amount of reagent from typical 50 µL to 15 µL, and required only simple equipment setup. Moreover, the limit of detection for glass capillary anti-p53 autoantibody immunoassay was 0.46 ng mL−1, which is close to the 0.19 ng mL−1 value of the conventional 96-well plate assay, and the glass capillary method had a broader detection range. The apparatus was used to detect the serum anti-p53 autoantibody concentration in clinical patients and compare its results with the conventional 96-well plate method results, which suggested that both of the methods detect the same trend in the relative concentration of serum anti-p53 autoantibody in healthy individuals or patients with OSCC.
APA, Harvard, Vancouver, ISO, and other styles
8

Rossi, Brian, Francesca Freni, Claudia Vignali, et al. "Comparison of Two Immunoassay Screening Methods and a LC-MS/MS in Detecting Traditional and Designer Benzodiazepines in Urine." Molecules 27, no. 1 (2021): 112. http://dx.doi.org/10.3390/molecules27010112.

Full text
Abstract:
Sensitive and specific immunoassay screening methods for the detection of benzodiazepines in urine represent an important prerequisite for routine analysis in clinical and forensic toxicology. Moreover, emerging designer benzodiazepines force labs to keep their methodologies updated, in order to evaluate the reliability of the immunochemical techniques. This study aimed at evaluating the sensitivity and specificity of two different immunoassay methods for the detection of benzodiazepines in urine, through a comparison with the results obtained by a newly developed liquid chromatographic tandem mass spectrometric (LC-MS/MS) procedure. A cohort of authentic urine samples (N = 501) were processed, before and after a hydrolysis procedure, through two immunoassays and an LC-MS/MS method. The LC-MS/MS target procedure was optimized for monitoring 25 different molecules, among traditional and designer benzodiazepines, including some metabolites. At least one of the monitored substances was detected in 100 out of the 501 samples. A good specificity was observed for the two immunoassays (>0.99), independently of the cut-offs and the sample hydrolysis. The new kit demonstrated a fairly higher sensitivity, always higher than 0.90; in particular, a high cross-reactivity of the new immunoassay was observed for samples that tested positive for lorazepam and 7-aminoclonazepam. The two immunoassays appeared adequate to monitor not only traditional benzodiazepines but also new designer ones.
APA, Harvard, Vancouver, ISO, and other styles
9

Luzzi, Veronica I., Al N. Saunders, John W. Koenig, et al. "Analytic Performance of Immunoassays for Drugs of Abuse Below Established Cutoff Values." Clinical Chemistry 50, no. 4 (2004): 717–22. http://dx.doi.org/10.1373/clinchem.2003.028878.

Full text
Abstract:
Abstract Background: The analytic performance and accuracy of drug detection below Substance Abuse and Mental Health Services Administration (SAMHSA) cutoffs is not well known. In some patient populations, clinically significant concentrations of abused drugs in urine may not be detected when current SAMHSA cutoffs are used. Our objectives were to define the precision profiles of three immunoassay systems for drugs of abuse and to evaluate the accuracy of testing at concentrations at which the CV was <20%. Methods: Drug-free urine was supplemented with analytes to assess the precision in three commercial drugs-of-abuse immunoassay systems below the SAMHSA-dictated cutoffs for amphetamines, opiates, benzoylecgonine, phencyclidine, and cannabinoids. Consecutive urine samples with signals associated with a CV <20% by Emit® immunoassay and below SAMHSA cutoffs were then subjected to confirmatory analysis. Results: The CV of all immunoassay systems tested remained <20% to drug concentrations well below SAMHSA cutoffs. The accuracy of urine drug-screening results between the SAMHSA-specified cutoffs and the precision-based cutoffs was less than accuracy for specimens above the SAMHSA cutoffs, but the use of the precision-based cutoff produced a 15.6% increase in the number of screen-positive specimens and a 7.8% increase in the detection of specimens that yielded positive results on confirmatory testing. Conclusion: The precision of three commercial immunoassay systems for drugs-of-abuse screening is adequate to detect drugs below SAMHSA cutoffs. Knowledge of the positive predictive values of screening immunoassays at lower cutoff concentrations could enable efficient use of confirmatory testing resources and improved detection of illicit drug use.
APA, Harvard, Vancouver, ISO, and other styles
10

Emerson, Jane F., Gilda Ngo, and Scott S. Emerson. "Screening for Interference in Immunoassays." Clinical Chemistry 49, no. 7 (2003): 1163–69. http://dx.doi.org/10.1373/49.7.1163.

Full text
Abstract:
Abstract Background: The presence of interfering substances in patient samples submitted for immunoassay cannot be reliably anticipated. We therefore evaluated three interference screening techniques and estimated the prevalence of interfering substances as defined by positive outcomes with these protocols. Methods: We evaluated 160 samples for the presence of substances that may interfere with four immunoassays (40 samples for each): thyroid-stimulating hormone, prostate-specific antigen, β-human chorionic gonadotropin, and cortisol. Interference was defined by nonlinear responses with serial dilution, discrepant results after pretreatment with heterophile blocking reagent (HBR), and positive reactions on a mouse-antibody-negative control reaction (Tandem ICON® ImmunoConcentration HCG). Criteria for declaring significant discrepant results were based on a Z-score computed using the assay CV. The McNemar test was used to compare the prevalence of discrepancies across the three screening techniques. The association between type of immunoassay and prevalence of discrepant results was determined by a modified Pearson χ2 statistic. Results: Five of the 160 samples [3.1%; 95% confidence interval (CI), 1.0–7.1%] screened positive with the ICON. Seventy-two of the 148 samples with informative serial dilutions (48.6%; 95% CI, 40.4–57.0%) had at least one discrepant result at higher dilutions. After pretreatment with HBR, 53 of the 140 samples (38%; 95% CI, 29.8–46%) were discrepant. Only 48 of the 140 samples with informative measurements for all three screening techniques (34%; 95% CI, 26–43%) were negative by all three. The prevalence of positive screens varied significantly by type of immunoassay (P <0.0001) for both HBR and serial dilution. Only 3% (0.8–7%) of the samples tested with HBR showed a change from normal to abnormal or the reverse after treatment. Conclusions: Introducing a protocol based on any of these three techniques into the immunochemistry laboratory to prescreen for interfering substances is not warranted. The evaluation of specimens for the presence of interfering anti-animal antibodies should be reserved for cases in which clinical history or suspicious results indicate the need.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Screening immunoassay"

1

Li, Dongfang. "Development of immunoassay screening methods using long wavelength fluorescence." Thesis, Loughborough University, 2004. https://dspace.lboro.ac.uk/2134/12905.

Full text
Abstract:
The developments of immunoassay methods for the early stage diagnosis of tuberculosis (TB) are described. These went through two different routes, one through flow injection analysis (FIA), and the other using immunochromatography methodology. The design of a simple longwavelength fluorescence detector to serve the above purposes has also been described. The FIA immunoassay methods involve immobilising antibodies on to beads, either directly or through protein A based solid phases. The beads are then packed into a micro-column reactor for incorporation into the FIA system. In this case reactor-bound molecules are eluted from the system by a change of pH, thus limiting the available fluorophores to those that are reasonably fluorescent in acid solution. Sandwich (reagent excess) assays have been investigated. A couple of long wavelength (600-800) fluorophores have been studied. The bead injection option has also been investigated. The immunochromatographic method uses a lateral flow system and a sandwich (two-site) immunometric assay. Capture antibodies are immobilised on a coated membrane matrix at a pre-determined position and the antigen is analysed after binding to a fluorescence-labelled antibody. Both fluorescent latex preparations and conventional fluorescent labels have been used and compared. The strips are simply immersed in a small volume of sample to start the analysis. The chromatographic step is rapid and extremely simple. The fluorescence detector is fitted with a motor-driven sample holder to allow the length of the immunochromatographic strip to be scanned. The detector utilises a diode laser light source, optical filters in the emission beam and a miniaturised photomultiplier. It can be easily modified for the FIA, and can readily be adapted to operate from batteries, so is suitable for field use.
APA, Harvard, Vancouver, ISO, and other styles
2

Hancox, Jill Nicola. "Sulfamethazine in food : a new approach to screening." Thesis, Loughborough University, 1998. https://dspace.lboro.ac.uk/2134/28127.

Full text
Abstract:
The aim of the research was to use the principles of immunoassays and fluorescence spectroscopy to detect the presence of 4-amino-N-(4,5- dimethyl-2-pyrimidinyl)benzenesulfonamide, commonly known as sulfamethazine, in food.
APA, Harvard, Vancouver, ISO, and other styles
3

Roberts, Beverley. "The development and critical evaluation of an immunoassay for hypoxanthine in biological matrices." Thesis, University of Surrey, 1986. http://epubs.surrey.ac.uk/847948/.

Full text
Abstract:
A classical radioimmunoassay for hypoxanthine was developed and validated. Hypoxanthine, being a low molecular weight compound (M.W. 136.11) is not immunogenic unless first attached to a macromolecule such as a protein. Derivatives of hypoxanthine were synthesised for this purpose. In addition to the standard preparation of 6-trichloromethyl purine, a derivative of this compound with a 4-carbon spacer arm was prepared, namely purine-6-carboxypropanamide. Hypoxanthine itself showed an unusual degree of stability, having no reactivity towards reagents when considered in either the keto or the enol form. The use of 6-chloropurine, a far more reactive analogue of hypoxanthine, resulted in the synthesis of a novel carboxymethoxylamine derivative, purine-6-carboxymethyl oxime. Four conjugates were prepared using ovalbumin as carrier protein. Hypoxanthine derivatives with a free carboxyl group were conjugated using the mixed anhydride method. 6-trichloromethyl purine was reactive enough to be coupled directly. Hypoxanthine-9-B-D-arabinofuranoside was coupled using the periodate oxidation method for sugar derivatives with vicinal hydroxyl groups. As the hapten was linked via the E-amino groups of lysine residues in each case, the molar derivatisation of each conjugate was calculated by measuring the number of free amino groups in the protein before and after conjugation using 2, 4, 6-trinitrobenzene sulphonic acid. With one of the conjugates ultraviolet spectrophotometric analysis, and calculation of the amount of purine removed during dialysis were also used for comparison and confirmation of the value obtained. The antisera were affinity purified and twelve reagents were compared for their ability to elute anti-hypoxanthine antibodies, whilst retaining immunoreactivity of the eluted fractions. For the determination of hypoxanthine by radioimmunoassay two phase separation systems were investigated, namely chemical precipitation of antigen-antibody complexes using ammonium sulphate, and adsorption of free hypoxanthine using activated charcoal. The antisera were shown to be highly specific for hypoxanthine, with cross-reactivities to six analagous compounds being < 0.1%, and crossreactivity to two further compounds, adenine and allopurinol being 1.9 and 3.2% respectively. Recovery of hypoxanthine added to samples was of the order of 97.3%, and the limit of detection was > 150 nmole/g. Inter-assay coefficient of variation for the data points for the hypoxanthine standard curve was < 10% for hypoxanthine concentrations below 125 nmole/ml. Inter-assay coefficient of variation for samples of fish extract containing hypoxanthine was approximately 12%. Hypoxanthine levels increased with time in samples of trout and whitebait, so that its concentration was indicative of quality, but hypoxanthine levels in liver decreased with length of storage time. Hypoxanthine concentrations in fish samples, as determined by radioimmunoassay, were compared with the values obtained using a well established spectrophotometric method. The correlation coefficient for the two methods was 0.84507 (n = 45) using hypoxanthine solutions extracted from whitebait and 0.93298 (n = 33) for samples of trout muscle, so establishing the radioimmunoassay as a technique for measuring the quality of such foods.
APA, Harvard, Vancouver, ISO, and other styles
4

Shimada, Kiyoshi, Yonju Ha, Akira Tsukada, et al. "In vivo and in vitro screening of endocrine disrupting chemicals with estrogenic activity in Japanese quail." Science Reviews 2000 Ltd, 2005. http://hdl.handle.net/2237/9265.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dobosz, Paulina Dorota. "Screening methodologies for the determination of water contaminant residues by compact disk technology." Doctoral thesis, Universitat Politècnica de València, 2017. http://hdl.handle.net/10251/79548.

Full text
Abstract:
[EN] The contamination of water resources with many industrial, agricultural and other chemicals is one of the key environmental problems that humanity is facing nowadays. Despite the fact that they are usually present at very low concentration, they possess a significant risk to aquatic and human life. To address this issue many national and international institutions set different regulations to monitor and control the water quality. Currently, the monitoring of compounds included in official watch lists is conducted by chromatographic and mass spectroscopic methods. These techniques are approved as "gold standards" for analytical quantitation of organic residues in water. Although they are sensitive and reproducible, cannot be used on-site. The need of sampling and centralized laboratory measurements makes not only the overall cost high but lowering the efficiency of the analysis. Therefore, there is an urgent need to develop suitable field methods to facilitate the in situ measurements at a low cost. Biosensors are therefore an alternative technology that can provide sensitive results in a fast and affordable way. This thesis has focused on the development of a biosensor based on immunoassays and compact disk technology, for the multiplex detection of priority water contaminants. As the methods based on the immunorecognition events are challenging in terms of the selectivity and sensitivity, the major part of the thesis was the selection of the immunoreagents, assay form and procedure. For the detection part, gold nanostructures were selected as sensitive tags for signal enhancement. Therefore, different nanoparticles were studied in order to select the optimal size in terms of the signal enhancement, sensitivity and antibody amount used. Also, the assays performances with signal enhancement and without any amplification were evaluated. The best immunoassay was selected for developing the multiplexed assay. Furthermore, an approach to improve the readout sensitivity of microimmunoassays based on used of gold nanoparticles as both capture and detection species was demonstrated. The method is based on the performance of the immunorecognition event in a homogeneous mode and detection part in the heterogeneous format. Finally, representative water samples were analysed to confirm the applicability of the multi-residue assay. The analytical properties have been established for each methodology and the obtained results have been validated by comparison with reference techniques. The investigations carried out in this work, have resulted in new insights in immunoassay technique that could be useful for screening applications.<br>[ES] La contaminación de aguas superficiales causada por plaguicidas y productos industriales es actualmente, uno de los grandes problemas medioambientales. Aunque estas sustancias están presentes a niveles muy bajos, tienen efectos perjudiciales en el medio en general y especialmente en humanos. Por este motivo, diferentes instituciones han regulado los niveles de contaminantes en áreas de controlar de la calidad de las aguas, creando listas prioritarias de sustancias peligrosas y tóxicas para el medio ambiente. Actualmente, la monitorización de los contaminantes incluidos en las listas oficiales se realiza mediante técnicas cromatográficas y espectrometría. Estos métodos analíticos están aprobados como técnicas de referencia para la determinación de residuos orgánicos presentes en aguas naturales. A pesar de ser técnicas fiables, reproducibles y sensibles, los métodos cromatográficos no están exentos de inconvenientes. Este tipo de metodologías requiere una instrumentación costosa y una laboriosa preparación de muestra, que hacen que el análisis sea en general complejo. Por ello, el desarrollo de métodos analíticos alternativos que faciliten hacer medidas in-situ a bajo coste y con gran capacidad de trabajo es de gran utilidad. En este sentido, las técnicas inmunoquímicas tienen un gran potencial analítico ya que son en general sensibles y selectivas, se pueden utilizar en el lugar de la toma de muestra y tienen capacidad multianalito. Esta tesis se ha centrado en el desarrollo de un sistema biosensor, basado en la tecnología de disco compacto, para la detección multianalito de diversos contaminantes prioritarios en aguas naturales. Las limitaciones más críticas para el desarrollo de un biosensor multianalito mediante métodos inmunoquímicos son los relacionados con su sensibilidad y selectividad. Por lo tanto, una parte importante de la tesis se ha centrado en la selección de inmunoreactivos, formato y optimización de diferentes parámetros claves del ensayo. Una estrategia utilizada para aumentar la sensibilidad de los ensayos ha consistido en marcar la inmunoreacción con nanopartículas de oro. Para ello, se ha estudiado diferentes tipos (esféricas y cilíndricas) de distinto tamaño y se han comparado sus prestaciones analíticas (relación señal ruido, sensibilidad etc.) También, se han desarrollado inmunoensayos cuantitativos sin necesidad de amplificación de la señal. Por otro lado, se ha desarrollado una aproximación que hemos denominado "inmunocaptura" basada en el uso de nanopartículas de oro como especie de captura de analitos en disolución y que actúa como marcador de la inmunointeracción que tiene lugar en la fase sólida. Finalmente, se han analizado muestras de agua naturales dopadas con distintos niveles de los analitos objeto de estudio para evaluar la utilidad de las metodologías desarrolladas como herramienta de screening masivo en el área medioambiental. Los resultados obtenidos han sido comparados con los obtenidos mediante las técnicas de referencia. Las investigaciones realizadas han permitido desarrollar nuevos formatos de ensayo y conocimientos inmunoquímicos aplicados a la tecnología de disco compacto, aportando nuevas herramientas de screening que permiten la determinación simultánea de contaminantes en aguas naturales por debajo de las concentraciones establecidas en la normativa europea de calidad de agua.<br>[CA] La contaminació d'aigües superficials causada principalment per plaguicides i altres productes industrials és un dels grans problemes mediambientals actuals. Malgrat que aquestes substàncies estan presents en nivells molt baixos, tenen efectes perjudicials en humans i animals. Per aquest motiu, diferents institucions estatals han regulat els nivells de contaminants en àrees de control de la qualitat de l'aigua, creant llistes prioritàries de substàncies perilloses i tòxiques per al medi ambient. Actualment, la monitorització dels contaminants inclosos en les llistes oficials es realitza mitjançant tècniques cromatogràfiques i d'espectroscòpia de masses. Aquests mètodes analítics estan aprovats com a tècniques de referència per a la determinació de residus orgànics presents en aigües naturals. Malgrat ser tècniques fiables, reproduïbles i sensibles, els mètodes cromatogràfics no estan exempts d'inconvenients. Aquest tipus de metodologies requereix una instrumentació costosa i una laboriosa preparació de mostres que fan que l'anàlisi sigui, en general, complex. Per això, el desenvolupament de mètodes analítics alternatius que facilitin la possibilitat de fer mesures in-situ a baix cost i amb gran capacitat analítica és de gran utilitat. En aquest sentit, les tècniques inmunoquímiques tenen un gran potencial analític ja que són, en general, sensibles i selectives, es poden utilitzar en el lloc de presa de la mostra i tenen capacitat multianalit. Aquesta tesi s'ha centrat en el desenvolupament d'un sistema biosensor, basat en la tecnologia de disc compacte, per a la detecció multianalit de diversos contaminants prioritaris en aigües naturals. Les limitacions més crítiques per al desenvolupament d'un biosensor multianalit mitjançant mètodes inmunoquímics són sensibilitat i selectivitat. Per tant, una part important de la tesi es va centrar en la selecció de inmunoreactius, format i optimització de diferents paràmetres clau de l'assaig. La detecció es va dur a terme mitjançant l'ús de nanopartícules d'or com a marcadors de la inmunointeracció i amplificació de la senyal analítica. S'han estudiat diferents estructures d'or (esferes i cilindres) de diferents tamanys, i s'han comparat les seves prestacions analítiques (relació senyal-soroll, sensibilitat, etc.). També s'han desenvolupat immunoassaigs quantitatius sense necessitat d'amplificació del senyal. Per altra banda, s'ha desenvolupat una aproximació que hem denominat "inmunocaptura", basada en l'ús de nanopartícules d'or com a espècie de captura d'analits en dissolució i que actua com a marcador de la inmunointeracció que té lloc en la fase sòlida. Finalment, s'han analitzat mostres d'aigües naturals dopades amb diferents nivells dels analits objecte d'estudi per avaluar la utilitat de les metodologies desenvolupades com a eina de "screening" massiu en l'àrea mediambiental. Els resultats obtinguts han sigut avaluats per comparació amb els obtinguts mitjançant tècniques de referència. Les investigacions realitzades han permès desenvolupar nous formats d'assaig i coneixements inmunoquímics aplicats a la tecnologia de disc compacte, aportant noves eines de "screening" que permetin la determinació de contaminants en aigües naturals per sota dels límits de concentració establerts per les normes internacionals de la qualitat de l'aigua.<br>Dobosz, PD. (2017). Screening methodologies for the determination of water contaminant residues by compact disk technology [Tesis doctoral no publicada]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/79548<br>TESIS
APA, Harvard, Vancouver, ISO, and other styles
6

Csonka, Enikö. "Method verification for aldosterone and renin assay - a reliable screening test for primary aldosteronism." Thesis, Uppsala universitet, Forskargrupper (Inst. för kvinnor och barns hälsa), 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358217.

Full text
Abstract:
Primary aldosteronism (PA) is a common form of secondary hypertension with an international prevalence rates between 5 and 10 %. It is characterized by a high autonomous aldosterone production that causes cardiovascular damage, renin suppression, hypertension, sodium retention, potassium excretion and hypokalemia. The screening of PA is a simple test measuring aldosterone to renin ratio (ARR) with immunoassay method. This test is currently considered as the most reliable screening tool for PA.     The main objective of the study was to evaluate an ELISA-method, for detection of aldosterone and renin in blood plasma, to be used for routine analysis in the laboratory. The second aim was to investigate the effect of refreezing samples, considering that cryoactivation of prorenin might occur.     One hundred blood samples were analysed, in regard to aldosterone and renin, by using two commercial ELISA assays (DRG ELISA from DRG Diagnostics, Germany) on a Dynex DS2 instrument. In addition, the accuracy and precision of the methods were calculated. The effect of refreezing was investigated with a series of eight samples, which were analyzed twice on the same instrument.     Both assays performed well. The resulting data showed good precision and accuracy. The correlation between the original and refreezed samples was good, r = 0.989 and r = 1.0 for aldosterone and renin respectively. Considering that the study only included eight samples, further investigation is recommended.     Evaluation showed that both immunoassays are reliable in diagnostic use and the ELISA-method is suitable to implement in the laboratory for routine analysis.
APA, Harvard, Vancouver, ISO, and other styles
7

Nording, Malin. "Rapid sample preparation and bioanalytical techniques for efficient screening of organic pollutants in the environment." Doctoral thesis, Umeå universitet, Kemi, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-842.

Full text
Abstract:
Large numbers of samples often need to be prepared and analysed in surveys of organic pollutants in the environment, but while the methods commonly used in such surveys can provide abundant detail they are generally costly, time-consuming and require large amounts of resources, so there is a need for simpler techniques. The work underlying this thesis assessed the potential utility of more convenient sample preparation and bioanalytical techniques for rapidly screening various environmental matrices that could be useful complements to higher resolution methods. Initially, the utility of a simplified extraction technique followed by an enzyme-linked immunosorbent assay (ELISA) for detecting polycyclic aromatic hydrocarbons (PAHs) in authentic (i.e. unspiked) contaminated soils was explored. The results showed that there are relationships between the structure and cross-reactivity among compounds that often co-occur with target PAHs. However, their potential contribution to deviations between estimates of total PAH contents of soils obtained using ELISA and gas chromatography-mass spectrometry (GC-MS) based reference methods were limited. Instead, the cross-reactivity of target PAHs and the failure to extract all of the PAHs prior to the ELISA determinations were the main reasons for these deviations. Polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) were detected in food and feed matrices, as well as in authentic contaminated soils using different bioanalytical techniques – ELISA and two cell-based bioassays: CAFLUX and CALUX (chemically activated fluorescent/luciferase gene expression) assays. In addition, enhanced sample preparation techniques based on accelerated solvent extraction (ASE) were developed. ASE with integrated carbon fractionation (ASE-C) in combination with CAFLUX produced estimates of PCDD and PCDF contents in fish oil and fish meal that agreed well with results obtained using reference methods. Furthermore, results from ELISA and GC-high resolution MS analyses of extracts of PCDD- and PCDF-contaminated soil samples obtained using an adjusted ASE-C technique were strongly correlated. Finally, the thesis reports the first experiments in which the results of CAFLUX, CALUX, and ELISA determinations of PCDDs and PCDFs in extracts of authentic contaminated soil samples were evaluated and compared to those obtained using a reference method. All of the bioanalytical techniques were found to be sufficiently sensitive, selective, and accurate for use in screening in compliance with soil quality assessment criteria. Overall, the improved sample preparation and bioanalytical techniques examined proved to be useful potential complements to conventional methods, enhancing the analytical framework for PAHs, PCDDs, and PCDFs. However, further validation has to be undertaken before they are applied on a large-scale.
APA, Harvard, Vancouver, ISO, and other styles
8

Johansson, Fredrik. "Microscale measurement of kinetic binding properties of monoclonal antibodies in solution using Gyrolab." Thesis, Uppsala universitet, Institutionen för biologisk grundutbildning, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-155575.

Full text
Abstract:
The number of monoclonal antibodies approved for therapeutic use has increased rapidlyover the last decade. As a consequence, precise and robust kinetic characterization techniquesare crucial in order to select the best suitable candidates. A kinetic characterization methodwas developed in Gyrolab with automated sample transfers. The characterization wasperformed in solution in a mixing CD, containing an integrated nanoliter mixing chamberwith affinity binding columns. Association rate constants were determined for four anti-TSHantibodies with values ranging from 3x105 M-1s-1 to 10x105 M-1s-1. The antibodies wereranked according to kass. Reproducibility
APA, Harvard, Vancouver, ISO, and other styles
9

Kolodych, Sergii. "Recherche de nouvelles réactions de couplage par criblage immuno-enzymatique." Thesis, Paris 11, 2013. http://www.theses.fr/2013PA112145.

Full text
Abstract:
La recherche de nouvelles réactions est un des enjeux fondamentaux de la chimie organique. En dehors de l’approche classique basée sur la conception d’une réaction en s’appuyant sur les propriétés chimiques des substrats, une nouvelle approche utilisant le criblage systématique de combinaisons aléatoires de fonctions réactives a été récemment adoptée par plusieurs groupes. Cette stratégie nécessite un outil analytique permettant de cribler un très grand nombre de réactions par jour et d’identifier les meilleures combinaisons conduisant à la formation de produits intéressants. Les travaux de thèse présentés dans ce mémoire s’inscrivent dans le contexte de l’utilisation des techniques de dosages immuno-enzymatiques (ELISA) comme outil de criblage pour la recherche de nouvelles réactions de couplage. Dans un premier temps le criblage de 2688 combinaisons de fonctions réactives et de catalyseurs choisies au hasard a été effectué. Ce criblage a permit de mettre en évidence deux nouveaux couplages en présence de sels de cuivre : une réaction entre les thiourées et les phénols conduisant à la formation des isourées et une réaction entre les N-hydroxythiourées et les alcynes conduisant à la formation des thiazole-2-imines. Dans un second temps le criblage de 2816 combinaisons de fonctions sélectionnées, cette fois-ci, de façon rationnelle a été effectué. Ce criblage a visé la découverte de nouvelles cycloadditions [3+2] répondant aux critères de la chimie « click ». Ainsi l’utilisation de dosage immuno-enzymatique a été étendue à l’optimisation des nouvelles réactions découvertes ainsi qu’à l’évaluation de leurs cinétique, chimiosélectivité et biocompatibilité. Près de 3000 tests complémentaires effectuées sur les « hits » issus du criblage primaire ont ainsi permit de mettre en évidence 4 nouvelles réactions de couplage dont une nouvelle réaction « click » : la cycloaddition sydnone-alcyne catalysée au cuivre (CuSAC). Dans la dernière partie de ce manuscrit les études plus détaillées sur la réaction CuSAC ont été effectuées, notamment l’identification de la structure du produit de couplage et l’étendue du champ d’application de cette réaction. Enfin, l’aspect « click » de la réaction CuSAC a été illustré par l’application de cette réaction au marquage d’une protéine<br>Discovery of new reactions is one of the fundamental goals in organic chemistry. In addition to the traditional approach to reaction discovery, consisting in designing a reaction on the basis of known chemical properties of reagents, new approaches based on the screening of random combinations of reactive functions and catalysts have been recently developed. The main prerequisite of this strategy is an analytical tool allowing screening of a big number of reactions per day and identifying combinations leading to the formation of unanticipated products. In the work presented herein a high-throughput immunoassay screening has been used for the discovery of new coupling reactions. In the first part of this work a screening of 2688 combinations of randomly chosen reactive functions and catalysts was carried out. This screening led to the discovery of two copper-promoted coupling reactions: a reaction between thioureas and phenols leading to the formation of isoureas through desulfurization; and a reaction between N-hydroxythioureas and alkynes leading to the formation of thiazole-2-imines. In the second part of the work a screening of 2816 combinations of rationally designed chemical functions and catalysts was carried out. This screening was focused on the discovery of catalytic [3+2] cycloadditions that comply with the standards of “click” chemistry. In this study, the use of immunoassay screening was extended to optimize new reactions and to evaluate their kinetics, chemoselectivity and biocompatibility. Therefore, around 3000 complementary tests were carried out on the hits, identified in the primary screening. This allowed the discovery of 3 new coupling reactions and one new “click” reaction: a copper-catalyzed sydnone-alkyne cycloaddition (CuSAC). The last part of the work was focused on detailed studies of the CuSAC reaction. Identification of the structure of the coupling product and substrate scope of this reaction was carried out. Finally, the applicability of the CuSAC reaction for bioconjugation was demonstrated by an example of protein labeling
APA, Harvard, Vancouver, ISO, and other styles
10

Sun, Xuan Pei, and 孫瑄珮. "Development of an in vitro immunoassay for Sec61-beta as a biomarker screening colorectal cancer." Thesis, 2011. http://ndltd.ncl.edu.tw/handle/10414383671349721425.

Full text
Abstract:
碩士<br>長庚大學<br>醫學生物技術暨檢驗學系<br>99<br>According to statistical data of Department of Health, Executive Yuan, R.O.C. (Taiwan), colorectal cancer (CRC) is the third common malignancy in Taiwan. Clinical symptoms are inconspicuous at an early stage of CRC, and it is always combine with metastasis at an advantage stage with 5 years survival rates lower than 10% in patients. Detection of the CRC during an early stage, that can decrease both the incidence and mortality of CRC. A previous study showed (unpublished), Sec61-β, a transmembrane protein that transported proteins pass the endoplasmic reticulum membrane, was overexpressed in 60% of tumor tissues from CRC patients. The western blot data showed 78% sensitivity and 69% specificity. Thus, our study expects to develop an ELISA kit to detect Sec61-β protein in CRC patients’ plasma. First, we prepared rabbit anti-Sec61-beta antibody against full length Sec61-β protein. But it showed low P value (P value= 0.4) in ELISA test. Therefore, We depart Sec61-β protein into two proteins by cloning two cDNA fragments , thus, we expect to obtain two different polyclonal antibodies against different Sec61-β protein site to improve the assay sensitivity and specificity.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Screening immunoassay"

1

Goolsby, D. A., E. M. Thurman, M. L. Clark, and M. L. Pomes. "Immunoassay as a Screening Tool for Triazine Herbicides in Streams." In ACS Symposium Series. American Chemical Society, 1990. http://dx.doi.org/10.1021/bk-1990-0451.ch008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lynch, K., and J. Shockley. "Case Study: Using Immunoassay Technology and a Dynamic Work Plan to Cost Effectively Achieve Site Cleanup and Statistical Certainty in Closure." In Field Screening Europe 2001. Springer Netherlands, 2002. http://dx.doi.org/10.1007/978-94-010-0564-7_34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Skoczenski, Brian A., Titan S. Fan, Jonathan J. Matt, J. Terry Pitts, and J. Larry Zettler. "Validation of an Immunoassay for Screening Chlorpyrifos-methyl Residues on Grain." In ACS Symposium Series. American Chemical Society, 1996. http://dx.doi.org/10.1021/bk-1996-0646.ch015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Harrison, Robert O. "Role of Quality Assurance in Immunoassay Methods Used for Field Screening." In ACS Symposium Series. American Chemical Society, 1997. http://dx.doi.org/10.1021/bk-1997-0657.ch029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Garcia-Castillo, Valeria, Leonardo Albarracin, Haruki Kitazawa, and Julio Villena. "Screening and Characterization of Immunobiotic Lactic Acid Bacteria with Porcine Immunoassay Systems." In Lactic Acid Bacteria. Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8907-2_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Albarracín, Leonardo, Valeria Garcia-Castillo, Julio Villena, and Haruki Kitazawa. "Screening and Characterization of Immunobiotic Lactic Acid Bacteria with Porcine Immunoassay Systems." In Methods in Molecular Biology. Springer US, 2024. http://dx.doi.org/10.1007/978-1-0716-4096-8_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ronkainen, Niina J., and Stanley L. Okon. "The Role of Immunoassays in Urine Drug Screening." In Advanced Healthcare Materials. John Wiley & Sons, Inc., 2014. http://dx.doi.org/10.1002/9781118774205.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tecleab, Awet, Alex K. Lyashchenko, and Alex J. Rai. "Quad Screen Test, A Multiplexed Biomarker Assay for Prenatal Screening to Assess Birth Defects: The Columbia University Experience Using the Beckman Access2 Immunoassay Analyzer and Benetech PRA." In Prenatal Diagnosis. Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8889-1_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Meyer-Almes, F. J. "Nanoparticle Immunoassays: A new Method for Use in Molecular Diagnostics and High Throughput Pharmaceutical Screening based on Fluorescence Correlation Spectroscopy." In Springer Series in Chemical Physics. Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-59542-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Luong, John H. T., and Sandeep K. Vashist. "Immunoassays for newborn screening." In Handbook of Immunoassay Technologies. Elsevier, 2025. https://doi.org/10.1016/b978-0-323-95509-6.00020-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Screening immunoassay"

1

Hendrickson, Olga Dmitrievna, Elena Anatolievna Zvereva, Ksenia Alekseevna Maksimova, Alexandra Pavlovna Bondarenko, and Sergey Aleksandrovich Eremin. "FLUORESCENT POLARIZATION IMMUNOASSAY OF MICROCYSTIN-LR." In NEW TECHNOLOGIES IN MEDICINE, BIOLOGY, PHARMACOLOGY AND ECOLOGY. Institute of information technology, 2021. http://dx.doi.org/10.47501/978-5-6044060-1-4.31.

Full text
Abstract:
To control the highly toxic phycotoxin microcystin-LR, which comtaminates food, a test sys-tem based on polarizing fluorescent immunoassay has been developed allowing for rapid screening testing, the detection limit of microcystin-LR is up to 7.5 ng / ml; duration of analy-sis – 10 min.
APA, Harvard, Vancouver, ISO, and other styles
2

Gao, Yali, Philip M. Sherman, Yu Sun, and Dongqing Li. "Multiplexed High-Throughput Electrokinetically-Controlled Immunoassay on a Chip for the Detection of Specific Bacterial Antibodies in Human Serum." In ASME 2007 International Mechanical Engineering Congress and Exposition. ASMEDC, 2007. http://dx.doi.org/10.1115/imece2007-42512.

Full text
Abstract:
This work presents a multiplexed electrokinetically-controlled heterogeneous immunoassay that can process ten samples in parallel. The immunoassay microchip was soft-lithographically fabricated using poly(dimethylsiloxane) and glass. Controlling parameters of the electrokinetically-driven flow in the microfluidic network was determined by numerically simulating transport processes. Multiple passively adsorbed antigens captured antibodies present in samples, which then bound with TRITC-labeled detection antibodies to generate fluorescent signals. Antibodies against Escherichia coli O157:H7 and Helicobacter pylori were studied as model analytes. After conditions for antigen-coating were optimized, a 24-minute assay detected E. coli O157:H7 antibody in the concentration range of 0.02–10 μg/mL, and H. pylori antibody in the range of 0.1–50 μg/mL. In testing human serum samples, non-specific binding of serum components was effectively suppressed by using 10% (w/v) bovine serum albumin. An accuracy of 100% was achieved in detecting either E. coli O157:H7 antibody or H. pylori antibody from human serum samples. Simultaneous screening of both antibodies was also successfully demonstrated. The immunoassay chip shows an excellent potential for efficiently detecting multiple pathogenic infections in clinical environments.
APA, Harvard, Vancouver, ISO, and other styles
3

Finkel, DJ, AE James, RA Felix, and GJ Wegner. "P3-18-07: Multiplex RTK Inhibitor Screening Utilizing a Plate-Based Immunoassay with Near-Infrared Detection." In Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/0008-5472.sabcs11-p3-18-07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mannuccl, P. M., and A. Tripodl. "DIAGNOSTIC SCREENING OF CONGENITAL THROMBOTIC SYNDROMES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643717.

Full text
Abstract:
The prevalence of inherited thrombotic syndromes in the general population (1 in 2,500/5,000) appears to be higher than that of inherited bleeding disorders. We have reviewed the problems of their diagnosis and propose a simple screening procedure. The most important candidates far. screening are patients with unexplained venous thromboembolism at ages ofless than 40 years, particularly when thrombotic episodes are recurrent.Screening must start from collectionof the clinical and family history of the propositus and from the exclusion of common acquired forms of thrombophilia. A negative family historydoes not exclude inherited thrombophilia, because the defects have oftena low penetrance and fresh mutationsmay have occurred in the propositi. The test chosen for laboratoryscreening of inherited thrombotic syndromes must be limited in number, easy todo and, more importantly, their results should be clinically relevent Which defects should be screened and what type of methodology should be used? The table is intended to answerthese questions by proposing a two-step screening procedure.The tests included in the .first step of the screening are aimed at evaluating Laboratory screening of inherited thrombotic syndromes the most frequent and well established causes of inherited thrombophilia, —-antithrombin III, protein C. protein S.plasminogen and fibrinogen.FIRST STEP Antithrombin III (heparin cofactorI chromogenic assay)Protein C (Francis' clotting assay)Protein S(electroimmunoassay of total proteinSantigen)Plasminogen (chromogenic assay)Fibrinogen (clotting assay)SECONSTEP(Tran's functional assay) Plasminogen activator (fibrin plate assay before and after venous stasisor DDAVP)Plasminogen activator inhibitor(chromogenic assay)The tests offirst choice that we propose (see table) are in general functional assaysdetecting both type I and type IIdeficiencies and are simple enough tobecarried out even in non specialized laboratories.For protein S, however,this goal has not been achieved yet and only type I protein S deficiencycan be currently identified with immunoassays measuring total protein S antigen. Since a number of laboratories may still not have the facilities to perform protein C functional assays, they are advised to set up at least an immunoassay, since type I deficiencies are much more frequent than type II deficiencies. The tests included in the second step of the screening are aimed at detectingthe less common or less well established causes of thrombophilia, and should be carried out when the clinical history suggests the existence of inherited thrombophilia and yet the first step has failed to reveal any laboratory abnormality. Defective plasminogen activation can be evaluated by measuring plasminogen activator activity with the simple fibrin plate assay carried out before and after stimuli such as venous occlusion and/or DDAVP infusion. The parallel measurement of plasminogen activator inhibitor allows to distinguish cases of detective plasminogen activation due to high inhibitor levels. The measurement of heparin cofactor II should also be included in this battery of second-step screening tests.Using this screening procedure in95 propositi with juvenile venous thromboembolism, we have identified 7 kindreds with antithrombin III deficiency (5 type I and 2 type II) (7.5%),7 kindreds with protein C deficiency (1 type II) (7.5%), 5 kindredswith protein S deficiency (5%), 1 withhypoplasminogenemia (1%) and 1 with dysfibrinogenemia Milano II (1). Theremaining undiagnosed cases might bedue to as yet unidentified deficiencies or abnormalities of other antithrombotic mechanisms such as,for instance, endothelial thrombomodulin or the fibrinolysis enhancing property of the protein C-protein S system.
APA, Harvard, Vancouver, ISO, and other styles
5

González Mota, Alba, Marina Covacho González, Isabel Valriberas Herrero, and Carlos Roncero Alonso. "Screening of cannabis use during pregnancy and neonates." In 22° Congreso de la Sociedad Española de Patología Dual (SEPD) 2020. SEPD, 2020. http://dx.doi.org/10.17579/sepd2020p090.

Full text
Abstract:
Introduction: Cannabis use in pregnancy is related to developmental and mental disorders. The acknowledgement of prenatal exposure frequently depends on the mother’s report, which can often be omitted. There exists little description in the literature of the different methods to detect the use of cannabis during pregnancy. Moreover, nowadays there is no standardized screening available. Objectives: The objective is to analyze the different methods of prenatal screening of cannabis during pregnancy. Methods: A systematic review of studies on the methods of screening of cannabis use during pregnancy and neonates was carried out in PubMed in July 2020 in English, French and Spanish including the last 10 years with the keywords: screening, test, detection, analysis, urine, blood, hair, meconium, lactation, milk, cannabis, marijuana, THC, pregnancy, pregnant, perinatal and prenatal. Results: 107 studies were analyzed, 52 studies included and 55 excluded. Urine toxicology is the most accurate method for maternal testing and depends on chronicity of use, since its duration varies from 2-3 days in occasional users to several weeks in chronic users. Neonatal meconium and umbilical cord tissue indicates fetal exposure to cannabinoids during second and third trimester, being cord tissue more rapidly available than meconium. Neonatal hair indicates third trimester exposure and it is less sensitive than meconium. Maternal serum and hair can also be used to assess cannabis use, being serum affected by chronicity with shorter half-life than urine, and hair less accurate than other drugs of abuse, lasting several weeks positive. To analyze the samples it typically involves a cleanup pretreatment, gas chromatography mass spectrometry (GC/MS), enzyme-linked inmunoabsorbent assay (ELISA) and/or an immunoassay screening and a liquid chromatography–tandem mass spectrometry (LC-MS/MS) confirmatory method. Conclusions: Standardized prenatal screening of cannabis during pregnancy using analytical methods for drug detection should be established to overcome the heterogeneity and improve clinical practice.
APA, Harvard, Vancouver, ISO, and other styles
6

Lancia, Maria, Tiffany Pang, Ashleigh Crawford, Jannah Wing, Khanjan Mehta, and Xuanhong Cheng. "A Novel E-Junction Lateral Flow Immunoassay for Widespread Sickle Cell Screening in Low and Middle-Income Countries." In 2020 IEEE Global Humanitarian Technology Conference (GHTC). IEEE, 2020. http://dx.doi.org/10.1109/ghtc46280.2020.9342918.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Elkhalifa, M., R. Abdulhadi, H. Ramadan, et al. "AB1044 Evaluation of a fluoroenzyme immunoassay (ELIA-CTD) in the screening of patients suspected for autoimmune connective tissue diseases." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.2679.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Elkhalifa, M., R. Abdulhadi, H. Ramadan, et al. "FRI0663 Evaluation of a fluoroenzyme immunoassay (ELIA-CTD) in the screening of patients suspected for autoimmune connective tissue diseases." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Selvam, Anjan Panneer, and Shalini Prasad. "Single Molecule Analysis Tool (SMAT) for Multiplexed Label-Free Assessment of Rare Cell Populations." In ASME 2014 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2014. http://dx.doi.org/10.1115/imece2014-40225.

Full text
Abstract:
A nanowell sensor for single molecular proteomic analysis of lung cancer has been designed. The nanowell sensor is an electrochemical immunoassay and comprises of a heterogenous nanoporous arrays integrated on to a gold microelectronic platform. The sensor operates on the principle of electrochemical impedance spectroscopy (EIS). Our approach to classification of lung cancer is based on screening for levels of expression of specific proteomic biomarkers associated with lung cancer stem cells. Proteomic activity for two lung cancer cell lines for two specific markers (ALDH1A1 and ALDH1A3) was quantified. Test samples prepared by synthetically spiking human pooled serum were tested and quantified for cancer stem cell marker activity. The lowest proteomic activity measured with (a) ALDH1A3 was 0.01 ng/mL and (b) ALDH1A1 was 1 ng/mL correlating to the detection of unit stem cell count.
APA, Harvard, Vancouver, ISO, and other styles
10

Jang, H. J., J. Y. Ahn, T. E. Bae, Y. B. Shin, M. G. Kim, and W. J. Cho. "Signal Enhancement of Human IL5 Immunoassay by Enzyme Catalyzed Ag Reduction Beyond Limit of Debye Screening Length on Ion-Sensitive Field Effect Transistors." In 2012 International Conference on Solid State Devices and Materials. The Japan Society of Applied Physics, 2012. http://dx.doi.org/10.7567/ssdm.2012.ps-11-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Screening immunoassay"

1

Thorne, Philip G., and Karen F. Myers. Evaluation of Commercial Enzyme Immunoassays for the Field Screening of TNT and RDX in Water. Defense Technical Information Center, 1997. http://dx.doi.org/10.21236/ada334972.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!